Ford AC - Search Results

1

Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.

Ford AC, Moayyedi P, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Reinisch W. Ford AC, et al. Am J Gastroenterol. 2015 May;110(5):716-24. doi: 10.1038/ajg.2015.117. Epub 2015 Apr 28. Am J Gastroenterol. 2015. PMID: 25916225 Free article.

2

Recent developments in gastroenterology.

Moayyedi P, Ford A. Moayyedi P, et al. BMJ. 2002 Dec 14;325(7377):1399-402. doi: 10.1136/bmj.325.7377.1399. BMJ. 2002. PMID: 12480858 Free PMC article. Review. No abstract available.

3

Mycophenolate mofetil in refractory inflammatory bowel disease.

Ford AC, Towler RJ, Moayyedi P, Chalmers DM, Axon AT. Ford AC, et al. Aliment Pharmacol Ther. 2003 Jun 1;17(11):1365-9. doi: 10.1046/j.1365-2036.2003.01581.x. Aliment Pharmacol Ther. 2003. PMID: 12786630 Free article.

4

How can the current strategies for Helicobacter pylori eradication therapy be improved?

Ford A, Moayyedi P. Ford A, et al. Can J Gastroenterol. 2003 Jun;17 Suppl B:36B-40B. doi: 10.1155/2003/714124. Can J Gastroenterol. 2003. PMID: 12845349

5

Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.

Ford A, Delaney B, Forman D, Moayyedi P. Ford A, et al. Cochrane Database Syst Rev. 2003;(4):CD003840. doi: 10.1002/14651858.CD003840. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003840. doi: 10.1002/14651858.CD003840.pub2. PMID: 14583996 Updated. Review.

6

Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.

Ford AC, Delaney BC, Forman D, Moayyedi P. Ford AC, et al. Am J Gastroenterol. 2004 Sep;99(9):1833-55. doi: 10.1111/j.1572-0241.2004.40014.x. Am J Gastroenterol. 2004. PMID: 15330927 Review.

7

Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.

Ford A, Delaney B, Forman D, Moayyedi P. Ford A, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003840. doi: 10.1002/14651858.CD003840.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003840. doi: 10.1002/14651858.CD003840.pub4. PMID: 15495066 Updated. Review.

8

Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.

Ford AC, Qume M, Moayyedi P, Arents NL, Lassen AT, Logan RF, McColl KE, Myres P, Delaney BC. Ford AC, et al. Gastroenterology. 2005 Jun;128(7):1838-44. doi: 10.1053/j.gastro.2005.03.004. Gastroenterology. 2005. PMID: 15940619

9

Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus.

Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P. Ford AC, et al. Am J Epidemiol. 2005 Sep 1;162(5):454-60. doi: 10.1093/aje/kwi218. Epub 2005 Aug 2. Am J Epidemiol. 2005. PMID: 16076833

10

A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Ford AC, et al. Gastroenterology. 2005 Dec;129(6):1910-7. doi: 10.1053/j.gastro.2005.09.016. Gastroenterology. 2005. PMID: 16344059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters